| 11/16/2026 3:18 PM | BAKER BROS. ADVISORS LP (1263508) Filed by Revolution Medicines (1628171) Subject | Form SCHEDULE 13G/A | |
| 11/16/2026 11:57 AM | Janus Henderson Group Ltd. (1274173) Filed by Revolution Medicines (1628171) Subject | Form SCHEDULE 13G/A | |
| 11/13/2026 5:00 PM | Borisy Alexis (1319446) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2026 5:00 PM | Anders Jack (1800668) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 5:00 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 6:56 AM | Anders Jack (1800668) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/05/2026 12:24 PM | FMR LLC (315066) Filed by Revolution Medicines (1628171) Subject | Form SCHEDULE 13G/A | |
| 11/04/2026 3:10 PM | Revolution Medicines (1628171) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/30/2026 11:36 AM | Revolution Medicines (1628171) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 10/28/2026 5:00 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/13/2026 3:32 PM | Revolution Medicines (1628171) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for RVMDW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/01/2026 5:00 PM | Revolution Medicines (1628171) Issuer Sandler Alan B. (1835966) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2026 5:00 PM | Cislini Jeff (1969082) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/28/2026 5:00 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/25/2026 3:17 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/24/2026 5:00 PM | ANDERSON ELIZABETH M (1758247) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2026 3:42 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/22/2026 5:00 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 3:13 PM | ANDERSON ELIZABETH M (1758247) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/18/2026 5:00 PM | Anders Jack (1800668) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 5:01 PM | Cislini Jeff (1969082) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 5:02 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 5:03 PM | Horn Margaret A (1294192) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 5:04 PM | Kelsey Stephen Michael (1462808) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 5:05 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 5:06 PM | Revolution Medicines (1628171) Issuer Sandler Alan B. (1835966) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 3:18 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 5:08 PM | Horn Margaret A (1294192) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 5:09 PM | Kelsey Stephen Michael (1462808) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 5:10 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 5:11 PM | Revolution Medicines (1628171) Subject Sandler Alan B. (1835966) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 5:00 PM | Kelsey Stephen Michael (1462808) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 5:05 PM | Anders Jack (1800668) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 5:06 PM | Cislini Jeff (1969082) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 5:07 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/14/2026 5:03 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2026 3:32 PM | Kelsey Stephen Michael (1462808) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/10/2026 4:52 PM | Kim Lorence H. (1643746) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 3:39 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/02/2026 3:30 PM | Kim Lorence H. (1643746) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 5:00 AM | Revolution Medicines (1628171) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |
| 08/31/2026 4:11 PM | Kim Lorence H. (1643746) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/26/2026 12:33 PM | Revolution Medicines (1628171) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/25/2026 3:06 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2026 3:06 PM | Cislini Jeff (1969082) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 3:37 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/21/2026 3:38 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/21/2026 3:38 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/21/2026 3:33 PM | Cislini Jeff (1969082) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2026 4:20 PM | FARALLON CAPITAL MANAGEMENT, L.L.C. (909661) Filed by Revolution Medicines (1628171) Subject | Form SCHEDULE 13G/A | |
| 08/13/2026 11:31 AM | Janus Henderson Group Ltd. (1274173) Filed by Revolution Medicines (1628171) Subject | Form SCHEDULE 13G | |
| 08/05/2026 3:10 PM | Revolution Medicines (1628171) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/01/2026 5:25 PM | Patel Sushil (1860609) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/29/2026 3:44 PM | Patel Sushil (1860609) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2026 3:35 PM | Anders Jack (1800668) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/23/2026 4:57 PM | Kim Lorence H. (1643746) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 4:42 PM | Borellini Flavia (1867426) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 4:43 PM | Patel Sushil (1860609) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 4:44 PM | Clyburn Frank (1763963) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 4:45 PM | Horning Sandra (1638709) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 4:45 PM | ANDERSON ELIZABETH M (1758247) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 4:52 PM | Borisy Alexis (1319446) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 7:00 AM | Revolution Medicines (1628171) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2026 6:51 PM | Horn Margaret A (1294192) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 5:23 PM | Cislini Jeff (1969082) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 5:30 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 5:07 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 5:15 PM | Anders Jack (1800668) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 4:59 PM | Kelsey Stephen Michael (1462808) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 4:51 PM | Horn Margaret A (1294192) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 3:59 PM | Horn Margaret A (1294192) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 3:05 PM | Horn Margaret A (1294192) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:46 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/15/2026 10:23 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Revolution Medicines (1628171) Subject | Form SCHEDULE 13G/A | |
| 05/06/2026 3:05 PM | Revolution Medicines (1628171) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 4:50 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/27/2026 4:30 PM | Revolution Medicines (1628171) Filer | Form DEF 14A | |
| 04/27/2026 3:32 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/17/2026 6:26 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 4:16 PM | Revolution Medicines (1628171) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/16/2026 4:06 PM | Revolution Medicines (1628171) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 4:24 PM | Revolution Medicines (1628171) Filer | Form 424B5 | |
| 04/15/2026 4:25 PM | Revolution Medicines (1628171) Filer | Form 424B5 | |
| 04/15/2026 3:53 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/15/2026 3:01 PM | Revolution Medicines (1628171) Filer | Form 305B2 | |
| 04/15/2026 5:00 AM | Revolution Medicines (1628171) Subject | Form FWP | |
| 04/13/2026 3:36 PM | Revolution Medicines (1628171) Filer | Form 424B5 | |
| 04/13/2026 3:39 PM | Revolution Medicines (1628171) Filer | Form 424B5 | |
| 04/13/2026 7:25 AM | Revolution Medicines (1628171) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 10:38 AM | Revolution Medicines (1628171) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/26/2026 7:01 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Every Starlink dish pays this stock (Ad) There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it.
Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th.
This free pick names the public company collecting on every unit. Claim your free stock pick before December 8th |
| 03/26/2026 7:04 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 5:44 PM | Mancini Anthony (2124509) Reporting Revolution Medicines (1628171) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/26/2026 5:35 PM | Revolution Medicines (1628171) Issuer Sandler Alan B. (1835966) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/19/2026 5:53 PM | Revolution Medicines (1628171) Issuer Wang Xiaolin (1849181) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/19/2026 5:54 PM | Cislini Jeff (1969082) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/19/2026 5:55 PM | Anders Jack (1800668) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/19/2026 5:56 PM | Horn Margaret A (1294192) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/19/2026 5:56 PM | GOLDSMITH MARK A (1246842) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/19/2026 5:57 PM | Kelsey Stephen Michael (1462808) Reporting Revolution Medicines (1628171) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |